Why is 3B Blackbio DX Ltd ?
1
The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of -5.80% and Operating profit at -18.44% over the last 5 years
3
The company has declared Positive results for the last 3 consecutive quarters
- NET SALES(9M) At Rs 119.27 cr has Grown at 70.09%
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 100.62 cr
- DEBTORS TURNOVER RATIO(HY) Highest at 2.83 times
4
With ROE of 18.1, it has a Very Expensive valuation with a 4 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.60%, its profits have risen by 13.2% ; the PEG ratio of the company is 1.8
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Consistent Returns over the last 3 years
- Along with generating 7.60% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to 3B Blackbio should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is 3B Blackbio for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
3B Blackbio
7.6%
0.16
46.85%
Sensex
-4.26%
-0.32
13.42%
Quality key factors
Factor
Value
Sales Growth (5y)
-5.80%
EBIT Growth (5y)
-18.44%
EBIT to Interest (avg)
37.28
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.42
Tax Ratio
24.30%
Dividend Payout Ratio
7.19%
Pledged Shares
0
Institutional Holding
4.65%
ROCE (avg)
25.69%
ROE (avg)
16.70%
Valuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
26
Price to Book Value
4.02
EV to EBIT
25.54
EV to EBITDA
22.58
EV to Capital Employed
5.32
EV to Sales
7.88
PEG Ratio
1.78
Dividend Yield
0.26%
ROCE (Latest)
22.76%
ROE (Latest)
18.06%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
No Trend
Technical Movement
13What is working for the Company
NET SALES(9M)
At Rs 119.27 cr has Grown at 70.09%
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 100.62 cr
DEBTORS TURNOVER RATIO(HY)
Highest at 2.83 times
-5What is not working for the Company
PBT LESS OI(Q)
At Rs 7.08 cr has Fallen at -38.65%
NON-OPERATING INCOME(Q)
is 46.44 % of Profit Before Tax (PBT
EPS(Q)
Lowest at Rs 11.12
Loading Valuation Snapshot...
Here's what is working for 3B Blackbio
Net Sales - Quarterly
At Rs 33.49 cr has Grown at 50.65%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 100.62 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Highest at 2.83 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for 3B Blackbio
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 7.08 cr has Fallen at -38.65%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 46.44 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Earnings per Share (EPS) - Quarterly
Lowest at Rs 11.12
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)






